Sector revisions Legend Biotech Corporation

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2026-03-11 EDT			5-day change	1st Jan Change
20.27 ^USD	+3.63%		+13.56%	-6.76%

03-11	Legend Biotech Shares Likely to Rebound in 2026 on Robust Fundamentals, RBC Says	MT
03-11	RBC Cuts Price Target on Legend Biotech to $62 From $66, Keeps Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
LEGEND BIOTECH CORPORATION				16
ARGENX SE				15
WUXI APPTEC CO., LTD.				18
INSMED INCORPORATED				19
BIONTECH SE				18
WUXI BIOLOGICS (CAYMAN) INC.				23
GENMAB A/S				14
AKESO, INC.				21
SUMMIT THERAPEUTICS INC.				13
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.				17
EXELIXIS, INC.				18
MADRIGAL PHARMACEUTICALS, INC.				14
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	-	1
REMEGEN CO., LTD.				15
VAXCYTE, INC.				9
ARROWHEAD PHARMACEUTICALS, INC.				11
IMMUNITYBIO, INC.				5
NUVALENT, INC.				17
CYTOKINETICS, INCORPORATED				18
Average				15
Weighted average by Cap.				16